https://www.lezdotechmed.com/blog/mass-tort/elmiron-lawsuit/
Unusual bladder pressure is a symptom of a chronic condition known as interstitial cystitis or bladder discomfort syndrome. It makes the patient experience pelvic discomfort and more likely to urinate often. According to estimates, 1.2 million women and 83,000 males in the U.S. have I.C.
The medication used to treat IC is ELMIRON®. Pentosan polysulfate sodium is a chemical component of ELMIRON®, a medication that comes in 100-mg capsules for oral use. Pentosan polysulfate is a member of the low molecular weight heparins class of anticoagulant drugs. It is a carbohydrate derivative that mimics glycosaminoglycans both chemically and physically. The majority of the medications in this class are used as blood thinners or anticoagulants.
Elmiron was created and produced by Janssen Pharmaceuticals Inc., a wholly-owned subsidiary of Johnson Johnson, with its headquarters in Beerse, Belgium. Paul Janssen established it in 1953, and Johnson Johnson later acquired it in 1961.
The FDA initially accepted Elmiron in 1996 to treat interstitial cystitis and discomfort in the bladder brought on by urinary tract infections (UTIs).
Elmiron was revered as the cure-all for I.C. sufferers up until 2018. When Atlanta's Emory Eye Center's Drs. Joseph T. Nezgoda and Nieraj Jain discovered pattern dystrophy in six patients, and the narrative turned surprisingly. After looking more closely at the patient histories, they found that every patient had taken Elmiron for around sixteen years.
Victims with eye injuries and visual issues brought on by Elmiron may bring a case against the company. According to the Elmiron Lawsuit Update 2022, the medicine producer is the target of almost 900 lawsuits. Elmiron (Pentosan Polysulfate Sodium) Product Liability Litigation, MDL 2973) was founded in 2021 and filed in the U.S. District Court for the District of New Jersey. The Elmiron litigation is being presided over by Judge Brian Martinotti.
In contrast to other medication MDLs, the Elmiron vision damage lawsuits have a robust research foundation demonstrating the medicine's toxicity in causing significant vision impairment. According to knowledgeable Elmiron attorneys, the Elmiron eye injury litigation will result in a large settlement.
The Elmiron lawsuit's settlement sum may change depending on how much harm the plaintiffs have suffered. A medical record review is an integral part of the Elmiron lawsuit to reflect the liability sustained by the plaintiff. LezDo techmed can assist you in reviewing medical records for cases like vaccine lawsuits, Gardasil lawsuits, Sunscreen lawsuits, hernia mesh lawsuits, and so on.
